StockMarketWire.com - Collagen Solutions has launched a new B to C web-based business in the US to sell standard collagen products directly to end users in the research market.

Collagen Solutions said this was an important initiative for the company as it directly connected it with end users in a cost effective manner while simultaneously addressing the purchasing needs of researchers.

Chief executive Jamal Rushdy said: "This initiative serves three purposes for Collagen Solutions.

"First, it increases our access to the estimated US$200m global market for cell culture reagents.

"Secondly, it gives us a direct link with the end users of our products so that we can understand their needs and how the market for collagen is evolving.

"Finally, it establishes Collagen Solutions as the go-to collagen supplier among investigators whose research will guide the rapidly advancing world of regenerative medicine."


At 9:40am: [LON:COS] Collagen Solutions Plc share price was +0.25p at 5.13p



Story provided by StockMarketWire.com